BridgeBio Pharma (BBIO) Intangibles: 2021-2025
Historic Intangibles for BridgeBio Pharma (BBIO) over the last 4 years, with Sep 2025 value amounting to $28.8 million.
- BridgeBio Pharma's Intangibles rose 17.41% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 17.41%. This contributed to the annual value of $23.9 million for FY2024, which is 9.09% down from last year.
- BridgeBio Pharma's Intangibles amounted to $28.8 million in Q3 2025, which was down 2.43% from $29.5 million recorded in Q2 2025.
- Over the past 5 years, BridgeBio Pharma's Intangibles peaked at $46.2 million during Q3 2021, and registered a low of $23.9 million during Q4 2024.
- For the 3-year period, BridgeBio Pharma's Intangibles averaged around $26.8 million, with its median value being $26.9 million (2023).
- Per our database at Business Quant, BridgeBio Pharma's Intangibles crashed by 36.56% in 2022 and then climbed by 17.47% in 2025.
- BridgeBio Pharma's Intangibles (Quarterly) stood at $44.9 million in 2021, then tumbled by 36.10% to $28.7 million in 2022, then fell by 8.33% to $26.3 million in 2023, then declined by 9.09% to $23.9 million in 2024, then increased by 17.41% to $28.8 million in 2025.
- Its last three reported values are $28.8 million in Q3 2025, $29.5 million for Q2 2025, and $27.8 million during Q1 2025.